Target intelligence / Profile preview

Microbial flora balance

Molecular classification
Other
01

Overview

"Microbial flora balance" refers to the optimal state of equilibrium among the microbial populations, mainly bacteria, colonizing a specific site—most notably the human gut. This state of eubiosis is crucial for digestion, metabolism, immune regulation, and pathogen resistance. Disruptions (dysbiosis) have been linked to a range of local and systemic diseases, including inflammatory and infectious diseases, metabolic syndrome, allergies, and neurodegenerative conditions. Interventions to restore microbial balance include probiotics, prebiotics, fecal microbiota transplantation, antibiotics (to reduce select pathogens), and dietary modification. The concept is a systems-level property rather than a druggable molecular entity.

Other names
Gut microbial balanceMicrobiota homeostasisMicrobial community equilibriumEubiosisMicrobiome balance
02

Mechanism of action

Restoration of microbial diversity (e.g., FMT); Modulation of metabolite production (via probiotics/prebiotics); Pathogen suppression (via competitive exclusion and antimicrobial peptide production); Immune response modulation (via changes in microbial metabolites and antigen stimulation)

03

Biological functions

Maintenance of digestive functionNutrient absorptionImmune modulationPathogen exclusionBarrier integrity regulationMetabolism of xenobioticsVitamin synthesis
04

Disease associations

Inflammatory bowel diseaseInfection (e.g., recurrent *Clostridium difficile*)Metabolic disordersNeurodegenerative disease (e.g., Alzheimer’s disease, Parkinson’s disease)Autoimmune disordersAllergiesOther
05

Safety considerations

Risk of infection with non-standardized FMTOff-target effects of antibiotics (dysbiosis)Allergic or intolerant reactions to probiotics/prebioticsLong-term ecological impacts and unpredictable changes in microbiota composition
06

Interacting drugs

Probiotics

4 more in the full profile.

07

Biomarkers

Shifts in microbiota composition (via 16S rRNA or metagenomic sequencing)Intestinal permeability markers (e.g., zonulin)Microbial metabolite profiles (e.g., short-chain fatty acids, bile acids)Inflammatory cytokines in plasma or stool

Beyond the preview

Go deeper on Microbial flora balance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial flora balance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call